Long-lived, immunologically vigorous (C3Hf X Af)Fl hybrids were produced after lethal irradia-
diated hybrid mice, but Af cells of young mice as well as of older mice produced graft-versus-host reaction and early death in irradiated C3Hf or (C3Hf X Af)F1 hybrids.
Abrogation of secondary disease by treatment of irradiated mice with spleen cells from allogeneic neonatally thymectomized mice is possibly attributable to diminished immunologic competence of the cells grafted, followed by the development of immunological tolerance of the dohor cells. Donor cells, receiving thymus influence in the recipient host after-. transplantation, could explain the long-lived immunologically vigorous radiation chimeras that did not experience graft-versus-host reactions. The fitidings.of this study help to understand the differential susceptibility of Af and C3Hf mice to development of tolerance to one another's antigens observed in prior investigations.
It appears that, in these mice, the host thymus influences the maturation of the spleen cells from young mice or from neonatally thymectomized mice. However, this influence was often greater in mice given 767 rads than in those given 1046 rads. This differential influence is possibly attributable to irradiation damage to the thymus produced by the higher dose of irradiation. Spleen cells from neonatally thymectomized mice can be differentiated and expanded by the thymus of the host. The differential susceptibility of T., early differentiation stages, of thymusdependent lymphocytes and T2, late differentiation stages, of thymus-dependent lymphocytes to tolerance induction and immunostimulation, respectively, are proposed as the bases for these otherwise paradoxical influences.
Clinical application of transplantation of allogeneic bone marrow or lymphoid tissue is difficult, mainly because of complications from graft-versus-host disease (1) or from immune inadequacy produced by immunosuppression to permit the grafting across major histocompatibility barriers (2) (3) (4) . It has generally been accepted that histocompatibility differences between donor and host underlie a graft-versus-host reaction that leads to the development of secondary disease in allogeneic radiation chimeras. Other factors influencing the outcome of hematopoietic transplants in allogeneic radiation chimeras include atrophy of supporting components of lymphatic tissues (5), late consequences of irradiation damage (6) , and infection (7) . On the other hand, radiation chimeras often have impaired immune capability (2) (3) (4) $ One mouse had a tumor, 0.8 cm in diameter, 15 days after transplant but it regressed 10 days later. § One mouse had a tumor, 1 cm in diameter, 12 days after transplant but it regressed 12 days later.
to approximate, in a model system, the problems of the severe combined immunodeficiency disease of children, and to attempt to address some of these problems with resources that con be reasonably well defined.
MATERIALS AND METHODS
Inbred mice of strains Af, C3Hf, BALB/c, (C3Hf X Af)F1, (Af X C57BL/1)FI, and-(C3Hf X C57BL/1)F1 (University of Minnesota strains) were used. Animals were cared for as described (9) . Mice of both sexes were used. Techniques for neonatal thymectomy and preparation of cell suspensions have been described (9, 10) . Groups of 20 mice of 10-to 15-day-old and 35-to 45-day-old thymectomized or nonthymectomized mice of Af, C3Hf, or (C3Hf X Af)F1 strains were used as donors. Mice of 3 months of age received either 550 or 750 exposure to irradiation (220 kV, 15 mA, 0.25-mm copper filter and 1 mm of aluminum, target distance of 60 cm, halfvalue layer of 0.98 mm of copper). The exposure values corrected for backscatter factor and converted into dose would be 767 rads and 1046 rads. The irradiated mice were divided into groups and injected with 50 X 100 spleen cells given intravenously into the tail vein. The mice were weighed once a week and observed every day so that survival could be scored. Six months after irradiation and treatment with spleen cells, the (C3Hf X AO)F, mice were given a single intraperitoneal injection of 0.1 ml of 20% sheep erythrocytes. All mice were bled from the tail 8 days later, and the titers of agglutinating antibodies were determined (11) . Seven months after irradiation, some groups of mice were injected with 0.1 ml of a 35% suspension of a tumor induced by DMBA (7,12, dimethyl- benz[a]anthracene) in the Is strain of mice. The tumor was inoculated subcutaneously in the skin of the neck, 30 days before the mice were killed. Other groups of mice (C3Hf) were grafted with skin from (C3Hf X Af)F1 and BALB/c at 7 months of age. They were killed and tested at 8-9 months of age by the discriminating graft-versus-host assay of Simonsen (9) .
RESULTS
Protection of Irradiated (C3Hf X Af)Fl Mice by Syngeneic and Allogeneic Spleen Cells. As can be seen in Fig. 1 (Fig. 2) . Fifty-four percent of the irradiated F1 hybrid mice given A strain spleen cells from 35-to 45-day-old thymectomized donors and 60% of those given spleen cells from 10-to 15-day- Another interesting aspect of these investigations was the finding that suggests that 1046 rads of total body irradiation may interfere with thymic function. The C3Hf mice given 1046 rads and treated with C3Hf, Af strain, and (C3Hf X Af)F1 hybrid spleen cells showed less vigor in skin allograft rejection and in capacity to initiate graft-versus-host reactions with either host or donor characteristics than did mice similarly treated that were given only 767 rads.
The irradiation did not abolish the inductive function of the thymus of the host, since the long-lived F1 hybrid mice produced by engrafting of spleen cells obtained from neonatally thymectomized mice showed immunologic vigor comparable to control nonirradiated and nontreated mice. However, the analysis of the immunocompetence of the C3Hf irradiated mice showed that both host and donor cells of the groups of mice given 767 rads recovered more completely than the cells of the mice given 1046 rads. This finding suggests that the irradiation injury of the thymic stroma may be dosedependent and that a threshold can be exceeded in some of our experiments by 1046 rads. These findings seem to us highly relevant to efforts to treat severe combined immunodeficiency in man by bone-marrow grafting of unrelated individuals. From our studies, one might predict that giving populations of cells deficient in differentiated post-thymic cells and rich in undifferentiated post-thymic cells or a mixture of undifferentiated post-thymic and prethymic cells may be most useful in the treatment of severe combined immunodeficiency diseases in man when an HLA-MLR-S identical sibling or an MLR-S match of a family member or an MLR-S match from the general population is not available as a donor (13) (14) (15) . Indeed, it is quite possible that a fetal liver transplant, which may have corrected the immunodeficiency of one child with severe combined immunodeficiency disease and adenosine deaminase deficiency without producing serious graft-versus-host reaction as reported by Keightly et al. (personal communication), may be an example of this principle in operation.
Experiments parallel to those carried out here in which early fetal-liver cells treated with monospecific anti-O serum are used to reconstitute lethally irradiated C3Hf mice and additional experiments using fetal-liver cells from older C3Hf or Af fetuses to treat lethally irradiated (C3Hf X Af)Fl recipients seem of high priority. Furthermore, comparison of the capacity of thymuses both within and without Millipore chambers from irradiated mice to produce immunologic reconstitution of neonatally thymectomized mice, represents studies much needed to complete our understanding of issues raised in this investigation.
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